Literature DB >> 6208117

Nontuberculous mycobacterial infections: comparison of the fluorescent auramine-O and Ziehl-Neelsen techniques in tissue diagnosis.

S Kommareddi, C R Abramowsky, G L Swinehart, L Hrabak.   

Abstract

Nontuberculous (i.e., atypical) mycobacterial infections are increasing among pediatric and immunosuppressed patients, who commonly present with subcutaneous inflammatory masses or adenitis, which is often surgically excised. Since the most frequently isolated species also grow slowly in culture, early diagnosis may depend on histologic detection of a mycobacterial organism in the biopsy specimen. However, the histologic methods used for this purpose are of uncertain value in the diagnosis of these infections. Biopsy specimens from 22 patients with clinical histories highly consistent with nontuberculous mycobacteriosis in which part of the tissue was cultured were selected for study. Coded tissue blocks and control specimens were stained by the Ziehl-Neelsen (ZN) or auramine-O (A0) fluorescent technique and examined blindly for the presence of characteristic organisms. Results of these studies were compared with the culture results, and predictive values were calculated. This experience showed that the AO technique is technically simpler, allowing faster screening at lower power and showing greater sensitivity and predictive value of a negative result although less specificity than the ZN technique. The lower specificity of AO may be factitious and due to the detection in the tissue of organisms that did not grow in culture. Previous observations that nontuberculous mycobacterial infections may elicit tissue reactions that simulate cat-scratch disease, sarcoidosis, and nonspecific chronic inflammation were also confirmed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208117     DOI: 10.1016/s0046-8177(84)80253-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

Review 1.  Detection of infection or infectious agents by use of cytologic and histologic stains.

Authors:  G L Woods; D H Walker
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

Review 2.  General and advanced diagnostic tools to detect Mycobacterium tuberculosis and their drug susceptibility: a review.

Authors:  Md A Gazi; Md R Islam; Mohammad G Kibria; Z Mahmud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-06       Impact factor: 3.267

3.  Rapid diagnosis of sputum negative miliary tuberculosis using the flexible fibreoptic bronchoscope.

Authors:  W S Kwee
Journal:  Thorax       Date:  1987-05       Impact factor: 9.139

4.  Molecular epidemiology of Mycobacterium tuberculosis in the United States-Affiliated Pacific Islands.

Authors:  Sapna Bamrah; Edward Desmond; Smita Ghosh; Anne Marie France; J Steve Kammerer; Lauren S Cowan; Andrew Heetderks; Alstead Forbes; Patrick K Moonan
Journal:  Asia Pac J Public Health       Date:  2012-12-13       Impact factor: 1.399

5.  Diffuse granulomatous lung disease: combined pathological-HRCT approach.

Authors:  Giorgia Dalpiaz; Marco Piolanti; Alessandra Cancellieri; Libero Barozzi
Journal:  Radiol Med       Date:  2014-02-01       Impact factor: 3.469

Review 6.  Diagnosis of active tuberculosis disease: From microscopy to molecular techniques.

Authors:  Adam J Caulfield; Nancy L Wengenack
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2016-05-25

Review 7.  Histopathologic review of granulomatous inflammation.

Authors:  Kabeer K Shah; Bobbi S Pritt; Mariam P Alexander
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2017-02-10

8.  Radiomics and machine learning for the diagnosis of pediatric cervical non-tuberculous mycobacterial lymphadenitis.

Authors:  Yarab Al Bulushi; Christine Saint-Martin; Nikesh Muthukrishnan; Farhad Maleki; Caroline Reinhold; Reza Forghani
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.996

9.  Prompt identification of primary cutaneous nocardiosis with immunohistochemical staining.

Authors:  Mark M Ash; Judy Hamad; Carolyn M Ziemer; Paul B Googe
Journal:  JAAD Case Rep       Date:  2020-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.